Quality of Life Assessment in Patients Using Benzodiazepines during the COVID-19 Pandemic in a Community Pharmacy Using EuroQol 5D-3L
Users of benzodiazepines (BZDs) should have their quality of life monitored to minimize the risks associated with long-term treatments. The aim of this study is to use the EuroQol 5D-3L to analyze the quality of life of 127 patients under treatment with BZDs during the COVID-19 pandemic. The results...
Saved in:
Main Authors: | Daida Alberto Armas (Author), Juan Ramón Santana Ayala (Author), Yanira Román Castillo (Author), Arturo Hardisson de la Torre (Author), Carmen Rubio Armendáriz (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Characterization in Patients Using Benzodiazepines While Providing Pharmaceutical Care Dispensing Service
by: Daida Alberto Armas, et al.
Published: (2024) -
EuroQol Toddler and Infant Populations (EQ-TIPS): Age-Related Differences in Performance
by: Janine Verstraete, et al.
Published: (2024) -
A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample
by: Mozzi A, et al.
Published: (2016) -
Intervenciones farmacéuticas en usuarios de benzodiacepinas durante la pandemia COVID-19
by: Daida Alberto-Armas, et al.
Published: (2024) -
Comparative performance of the EuroQol EQ-5D-5L and the CDC healthy days measures in assessing population health
by: Maryna Derkach, et al.
Published: (2022)